Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1326

1.

EANO-EURACAN clinical practice guideline for diagnosis, treatment, and follow-up of post-pubertal and adult patients with medulloblastoma.

Franceschi E, Hofer S, Brandes AA, Frappaz D, Kortmann RD, Bromberg J, Dangouloff-Ros V, Boddaert N, Hattingen E, Wiestler B, Clifford SC, Figarella-Branger D, Giangaspero F, Haberler C, Pietsch T, Pajtler KW, Pfister SM, Guzman R, Stummer W, Combs SE, Seidel C, Beier D, McCabe MG, Grotzer M, Laigle-Donadey F, Stücklin ASG, Idbaih A, Preusser M, van den Bent M, Weller M, Hau P.

Lancet Oncol. 2019 Dec;20(12):e715-e728. doi: 10.1016/S1470-2045(19)30669-2. Review.

PMID:
31797797
2.

Bevacizumab versus alkylating chemotherapy in recurrent glioblastoma.

Seystahl K, Hentschel B, Loew S, Gramatzki D, Felsberg J, Herrlinger U, Westphal M, Schackert G, Thon N, Tatagiba M, Pietsch T, Reifenberger G, Löffler M, Wick W, Weller M; German Glioma Network.

J Cancer Res Clin Oncol. 2019 Nov 21. doi: 10.1007/s00432-019-03086-9. [Epub ahead of print]

PMID:
31754832
3.

My Baby's Movements: a stepped wedge cluster randomised controlled trial to raise maternal awareness of fetal movements during pregnancy study protocol.

Flenady V, Gardener G, Boyle FM, Callander E, Coory M, East C, Ellwood D, Gordon A, Groom KM, Middleton PF, Norman JE, Warrilow KA, Weller M, Wojcieszek AM, Crowther C; IMPACT Clinical Trials Network for Mothers’ and Babies’ Health.

BMC Pregnancy Childbirth. 2019 Nov 21;19(1):430. doi: 10.1186/s12884-019-2575-1.

4.

Longitudinal molecular trajectories of diffuse glioma in adults.

Barthel FP, Johnson KC, Varn FS, Moskalik AD, Tanner G, Kocakavuk E, Anderson KJ, Abiola O, Aldape K, Alfaro KD, Alpar D, Amin SB, Ashley DM, Bandopadhayay P, Barnholtz-Sloan JS, Beroukhim R, Bock C, Brastianos PK, Brat DJ, Brodbelt AR, Bruns AF, Bulsara KR, Chakrabarty A, Chakravarti A, Chuang JH, Claus EB, Cochran EJ, Connelly J, Costello JF, Finocchiaro G, Fletcher MN, French PJ, Gan HK, Gilbert MR, Gould PV, Grimmer MR, Iavarone A, Ismail A, Jenkinson MD, Khasraw M, Kim H, Kouwenhoven MCM, LaViolette PS, Li M, Lichter P, Ligon KL, Lowman AK, Malta TM, Mazor T, McDonald KL, Molinaro AM, Nam DH, Nayyar N, Ng HK, Ngan CY, Niclou SP, Niers JM, Noushmehr H, Noorbakhsh J, Ormond DR, Park CK, Poisson LM, Rabadan R, Radlwimmer B, Rao G, Reifenberger G, Sa JK, Schuster M, Shaw BL, Short SC, Smitt PAS, Sloan AE, Smits M, Suzuki H, Tabatabai G, Van Meir EG, Watts C, Weller M, Wesseling P, Westerman BA, Widhalm G, Woehrer A, Yung WKA, Zadeh G, Huse JT, De Groot JF, Stead LF, Verhaak RGW; GLASS Consortium.

Nature. 2019 Dec;576(7785):112-120. doi: 10.1038/s41586-019-1775-1. Epub 2019 Nov 20.

PMID:
31748746
5.

INTELLANCE 2/EORTC 1410 randomized phase II study of Depatux-M alone and with temozolomide vs temozolomide or lomustine in recurrent EGFRamplified glioblastoma.

van den Bent M, Eoli M, Sepulveda JM, Smits M, Walenkamp A, Frenel JS, Franceschi E, Clement PM, Chinot O, de Vos F, Whenham N, Sanghera P, Weller M, Dubbink HJ, French P, Looman J, Dey J, Krause S, Ansell P, Nuyens S, Spruyt M, Brilhante J, Coens C, Gorlia T, Golfinopoulos V.

Neuro Oncol. 2019 Nov 20. pii: noz222. doi: 10.1093/neuonc/noz222. [Epub ahead of print]

PMID:
31747009
6.

YAP1-fusions in pediatric NF2-wildtype meningioma.

Sievers P, Chiang J, Schrimpf D, Stichel D, Paramasivam N, Sill M, Gayden T, Casalini B, Reuss DE, Dalton J, Pajtler KW, Hänggi D, Herold-Mende C, Rushing E, Korshunov A, Mawrin C, Weller M, Schlesner M, Wick W, Jabado N, Jones DTW, Pfister SM, von Deimling A, Ellison DW, Sahm F.

Acta Neuropathol. 2019 Nov 16. doi: 10.1007/s00401-019-02095-9. [Epub ahead of print] No abstract available.

PMID:
31734728
7.

Predisposing and precipitating risk factors for delirium in palliative care patients.

Seiler A, Schubert M, Hertler C, Schettle M, Blum D, Guckenberger M, Weller M, Ernst J, von Känel R, Boettger S.

Palliat Support Care. 2019 Nov 14:1-10. doi: 10.1017/S1478951519000919. [Epub ahead of print]

PMID:
31722766
8.

Symptom clusters in newly diagnosed glioma patients: which symptom clusters are independently associated with functioning and global health status?

Coomans MB, Dirven L, Aaronson NK, Baumert BG, Van Den Bent M, Bottomley A, Brandes AA, Chinot O, Coens C, Gorlia T, Herrlinger U, Keime-Guibert F, Malmström A, Martinelli F, Stupp R, Talacchi A, Weller M, Wick W, Reijneveld JC, Taphoorn MJB.

Neuro Oncol. 2019 Nov 4;21(11):1447-1457. doi: 10.1093/neuonc/noz118.

PMID:
31682733
9.

Tumors diagnosed as cerebellar glioblastoma comprise distinct molecular entities.

Reinhardt A, Stichel D, Schrimpf D, Koelsche C, Wefers AK, Ebrahimi A, Sievers P, Huang K, Casalini MB, Fernández-Klett F, Suwala A, Weller M, Gramatzki D, Felsberg J, Reifenberger G, Becker A, Hans VH, Prinz M, Staszewski O, Acker T, Dohmen H, Hartmann C, Paulus W, Heß K, Brokinkel B, Schittenhelm J, Buslei R, Deckert M, Mawrin C, Hewer E, Pohl U, Jaunmuktane Z, Brandner S, Unterberg A, Hänggi D, Platten M, Pfister SM, Wick W, Herold-Mende C, Korshunov A, Reuss DE, Sahm F, Jones DTW, Capper D, von Deimling A.

Acta Neuropathol Commun. 2019 Oct 28;7(1):163. doi: 10.1186/s40478-019-0801-8.

10.

Complementary and alternative medicine use in glioma patients in France.

Le Rhun E, Devos P, Bourg V, Darlix A, Lorgis V, Ahle G, Boone M, Taillandier L, Curtit E, Gras L, Lebrun Frenay C, Gramatzki D, Ramirez C, Simon N, Weller M.

J Neurooncol. 2019 Dec;145(3):487-499. doi: 10.1007/s11060-019-03315-8. Epub 2019 Oct 21.

PMID:
31637628
11.

Intrathecal liposomal cytarabine plus systemic therapy versus systemic chemotherapy alone for newly diagnosed leptomeningeal metastasis from breast cancer.

Le Rhun E, Wallet J, Mailliez A, Le Deley MC, Rodrigues I, Boulanger T, Lorgis V, Barrière J, Robin YM, Weller M, Bonneterre J.

Neuro Oncol. 2019 Oct 22. pii: noz201. doi: 10.1093/neuonc/noz201. [Epub ahead of print]

PMID:
31637444
12.

Synergistic growth inhibition mediated by dual PI3K/mTOR pathway targeting and genetic or direct pharmacological AKT inhibition in human glioblastoma models.

Von Achenbach C, Weller M, Kaulich K, Gramatzki D, Zacher A, Fabbro D, Reifenberger G, Szabó E.

J Neurochem. 2019 Oct 16. doi: 10.1111/jnc.14899. [Epub ahead of print]

PMID:
31618458
13.

Lymphatic outflow of cerebrospinal fluid is reduced in glioma.

Ma Q, Schlegel F, Bachmann SB, Schneider H, Decker Y, Rudin M, Weller M, Proulx ST, Detmar M.

Sci Rep. 2019 Oct 15;9(1):14815. doi: 10.1038/s41598-019-51373-9.

14.

Romiplostim for temozolomide-induced thrombocytopenia in glioblastoma: The PLATUM trial.

Le Rhun E, Devos P, Houillier C, Cartalat S, Chinot O, Di Stefano AL, Lepage C, Reyns N, Dubois F, Weller M.

Neurology. 2019 Nov 5;93(19):e1799-e1806. doi: 10.1212/WNL.0000000000008440. Epub 2019 Oct 4.

PMID:
31586022
15.

Underweight and weight loss are predictors of poor outcome in patients with brain metastasis.

Lareida A, Terziev R, Grossenbacher B, Andratschke N, Roth P, Rohrmann S, Stahel R, Guckenberger M, Le Rhun E, Weller M, Wolpert F.

J Neurooncol. 2019 Nov;145(2):339-347. doi: 10.1007/s11060-019-03300-1. Epub 2019 Sep 30.

PMID:
31571112
16.

Challenges in the diagnoses and treatment of CNS tumors.

Weller M.

Neurooncol Pract. 2019 Sep;6(5):329. doi: 10.1093/nop/npz044. Epub 2019 Sep 20. No abstract available.

PMID:
31555446
17.

Molecular targeted therapy of glioblastoma.

Le Rhun E, Preusser M, Roth P, Reardon DA, van den Bent M, Wen P, Reifenberger G, Weller M.

Cancer Treat Rev. 2019 Nov;80:101896. doi: 10.1016/j.ctrv.2019.101896. Epub 2019 Sep 11. Review.

PMID:
31541850
18.

Therapeutic Targeting of TGFβ Ligands in Glioblastoma Using Novel Antisense Oligonucleotides Reduces the Growth of Experimental Gliomas.

Papachristodoulou A, Silginer M, Weller M, Schneider H, Hasenbach K, Janicot M, Roth P.

Clin Cancer Res. 2019 Dec 1;25(23):7189-7201. doi: 10.1158/1078-0432.CCR-17-3024. Epub 2019 Sep 17.

PMID:
31530630
19.

Predisposing and precipitating factors for delirium in neurology: a prospective cohort study of 1487 patients.

Zipser CM, Deuel J, Ernst J, Schubert M, Weller M, von Känel R, Boettger S.

J Neurol. 2019 Dec;266(12):3065-3075. doi: 10.1007/s00415-019-09533-4. Epub 2019 Sep 13.

PMID:
31520105
20.

EANO Guideline on the Diagnosis and Treatment of Vestibular Schwannoma.

Goldbrunner R, Weller M, Regis J, Lund-Johansen M, Stavrinou P, Reuss D, Evans DG, Lefranc F, Sallabanda K, Falini A, Axon P, Sterkers O, Fariselli L, Wick W, Tonn JC.

Neuro Oncol. 2019 Aug 28. pii: noz153. doi: 10.1093/neuonc/noz153. [Epub ahead of print]

PMID:
31504802
21.

Risk factors for the development of epilepsy in patients with brain metastasis.

Wolpert F, Lareida A, Terziev R, Grossenbacher B, Neidert MC, Roth P, Poryazova R, Imbach L, Le Rhun E, Weller M.

Neuro Oncol. 2019 Sep 10. pii: noz172. doi: 10.1093/neuonc/noz172. [Epub ahead of print]

PMID:
31498867
22.

High-throughput proteomic analysis of FFPE tissue samples facilitates tumor stratification.

Zhu Y, Weiss T, Zhang Q, Sun R, Wang B, Yi X, Wu Z, Gao H, Cai X, Ruan G, Zhu T, Xu C, Lou S, Yu X, Gillet L, Blattmann P, Saba K, Fankhauser CD, Schmid MB, Rutishauser D, Ljubicic J, Christiansen A, Fritz C, Rupp NJ, Poyet C, Rushing E, Weller M, Roth P, Haralambieva E, Hofer S, Chen C, Jochum W, Gao X, Teng X, Chen L, Zhong Q, Wild PJ, Aebersold R, Guo T.

Mol Oncol. 2019 Nov;13(11):2305-2328. doi: 10.1002/1878-0261.12570. Epub 2019 Sep 18.

23.

Anticonvulsive effect of anterior thalamic deep brain stimulation in super-refractory status epilepticus crucially depends on active stimulation zone-A single case observation.

Imbach LL, Baumann CR, Poryazova R, Geissler O, Brugger P, Sarnthein J, Mothersill I, Weller M, Oertel MF, Stieglitz LH.

Seizure. 2019 Oct;71:286-288. doi: 10.1016/j.seizure.2019.08.015. Epub 2019 Aug 28. No abstract available.

PMID:
31493681
24.

FOCAD loss impacts microtubule assembly, G2/M progression and patient survival in astrocytic gliomas.

Brand F, Förster A, Christians A, Bucher M, Thomé CM, Raab MS, Westphal M, Pietsch T, von Deimling A, Reifenberger G, Claus P, Hentschel B, Weller M, Weber RG.

Acta Neuropathol. 2019 Aug 31. doi: 10.1007/s00401-019-02067-z. [Epub ahead of print]

PMID:
31473790
25.

Isolated perfused udder model for transcriptome analysis in response to Streptococcus agalactiae.

Weller MMDCA, Fonseca I, Sbardella AP, Pinto ISB, Viccini LF, Brandão HM, Gern JC, Carvalho WA, Guimarães AS, Brito MAVP, Munari DP, Silva MVGB, Martins MF.

J Dairy Res. 2019 Aug;86(3):307-314. doi: 10.1017/S0022029919000451.

PMID:
31451129
26.

Imaging challenges of immunotherapy and targeted therapy in patients with brain metastases: Response, Progression, and Pseudoprogression.

Galldiks N, Kocher M, Ceccon G, Werner JM, Brunn A, Deckert M, Pope WB, Soffietti R, Le Rhun E, Weller M, Tonn JC, Fink GR, Langen KJ.

Neuro Oncol. 2019 Aug 22. pii: noz147. doi: 10.1093/neuonc/noz147. [Epub ahead of print]

PMID:
31437274
27.

Cooperation of oncolytic virotherapy with VEGF-neutralizing antibody treatment in IDH wildtype glioblastoma depends on MMP9.

Wirsching HG, Arora S, Zhang H, Szulzewsky F, Cimino PJ, Quéva C, Houghton AM, Glorioso JC, Weller M, Holland EC.

Neuro Oncol. 2019 Aug 15. pii: noz145. doi: 10.1093/neuonc/noz145. [Epub ahead of print] No abstract available.

PMID:
31412117
28.

Management of low-grade glioma: a systematic review and meta-analysis.

Brown TJ, Bota DA, van Den Bent MJ, Brown PD, Maher E, Aregawi D, Liau LM, Buckner JC, Weller M, Berger MS, Glantz M.

Neurooncol Pract. 2019 Jul;6(4):249-258. doi: 10.1093/nop/npy034. Epub 2018 Aug 18. Review.

PMID:
31386075
29.

Complementary and alternative medicine use by glioma patients in Switzerland.

Eisele G, Roelcke U, Conen K, Huber F, Weiss T, Hofer S, Heese O, Westphal M, Hertler C, Roth P, Weller M.

Neurooncol Pract. 2019 May;6(3):237-244. doi: 10.1093/nop/npy035. Epub 2018 Oct 12.

PMID:
31386047
30.

Temporal muscle thickness is an independent prognostic marker in patients with progressive glioblastoma: translational imaging analysis of the EORTC 26101 trial.

Furtner J, Genbrugge E, Gorlia T, Bendszus M, Nowosielski M, Golfinopoulos V, Weller M, van den Bent MJ, Wick W, Preusser M.

Neuro Oncol. 2019 Aug 1. pii: noz131. doi: 10.1093/neuonc/noz131. [Epub ahead of print]

PMID:
31369680
31.

Decreased fetal movements (DFM) - finding the balance.

Gardener G, Weller M, Ellwood D, Flenady V.

Aust N Z J Obstet Gynaecol. 2019 Aug;59(4):E14. doi: 10.1111/ajo.13024. No abstract available.

PMID:
31368514
32.

Synthetic lethality between BRCA1 deficiency and poly(ADP-ribose) polymerase inhibition is modulated by processing of endogenous oxidative DNA damage.

Giovannini S, Weller MC, Repmann S, Moch H, Jiricny J.

Nucleic Acids Res. 2019 Sep 26;47(17):9132-9143. doi: 10.1093/nar/gkz624.

33.

Link between Photoelectron Circular Dichroism and Fragmentation Channel in Strong Field Ionization.

Fehre K, Eckart S, Kunitski M, Janke C, Trabert D, Rist J, Weller M, Hartung A, Schmidt LPH, Jahnke T, Dörner R, Schöffler M.

J Phys Chem A. 2019 Aug 1;123(30):6491-6495. doi: 10.1021/acs.jpca.9b04210. Epub 2019 Jul 22.

PMID:
31329435
34.

How we treat glioblastoma.

Weller M, Le Rhun E, Preusser M, Tonn JC, Roth P.

ESMO Open. 2019 Jun 17;4(Suppl 2):e000520. doi: 10.1136/esmoopen-2019-000520. eCollection 2019. Review.

35.

Arming oHSV with ULBP3 drives abscopal immunity in lymphocyte-depleted glioblastoma.

Wirsching HG, Zhang H, Szulzewsky F, Arora S, Grandi P, Cimino PJ, Amankulor N, Campbell JS, McFerrin L, Pattwell SS, Ene C, Hicks A, Ball M, Yan J, Zhang J, Kumasaka D, Pierce RH, Weller M, Finer M, Quéva C, Glorioso JC, Houghton AM, Holland EC.

JCI Insight. 2019 Jul 11;4(13). pii: 128217. doi: 10.1172/jci.insight.128217. eCollection 2019 Jul 11.

36.

Long-term complications and reconstruction failures in previously radiated breast cancer patients receiving salvage mastectomy with autologous reconstruction or tissue expander/implant-based reconstruction.

Manyam BV, Shah C, Woody NM, Reddy CA, Weller MA, Juloori A, Naik M, Valente S, Grobmyer S, Durand P, Djohan R, Tendulkar RD.

Breast J. 2019 Nov;25(6):1071-1078. doi: 10.1111/tbj.13428. Epub 2019 Jul 1.

PMID:
31264293
37.

Long-Term Outcomes After Autologous or Tissue Expander/Implant-Based Breast Reconstruction and Postmastectomy Radiation for Breast Cancer.

Manyam BV, Shah C, Woody NM, Reddy CA, Weller MA, Juloori A, Naik M, Valente S, Grobmyer S, Durand P, Djohan R, Tendulkar RD.

Pract Radiat Oncol. 2019 Nov;9(6):e497-e505. doi: 10.1016/j.prro.2019.06.008. Epub 2019 Jun 22.

PMID:
31238166
38.

How we treat patients with leptomeningeal metastases.

Le Rhun E, Preusser M, van den Bent M, Andratschke N, Weller M.

ESMO Open. 2019 May 21;4(Suppl 2):e000507. doi: 10.1136/esmoopen-2019-000507. eCollection 2019. Review.

39.

Data Sets for the Reporting of Tumors of the Central Nervous System.

Louis DN, Wesseling P, Brandner S, Brat DJ, Ellison DW, Giangaspero F, Hattab EM, Hawkins C, Judge MJ, Kleinschmidt-DeMasters B, Komori T, McLean C, Paulus W, Perry A, Reifenberger G, Weller M, Rous B.

Arch Pathol Lab Med. 2019 Jun 20. doi: 10.5858/arpa.2018-0565-OA. [Epub ahead of print]

PMID:
31219344
40.

The added value of health-related quality of life as a prognostic indicator of overall survival and progression-free survival in glioma patients: a meta-analysis based on individual patient data from randomised controlled trials.

Coomans M, Dirven L, K Aaronson N, Baumert BG, van den Bent M, Bottomley A, Brandes AA, Chinot O, Coens C, Gorlia T, Herrlinger U, Keime-Guibert F, Malmström A, Martinelli F, Stupp R, Talacchi A, Weller M, Wick W, Reijneveld JC, Taphoorn MJB; EORTC Quality of Life Group and the EORTC Brain Tumor Group.

Eur J Cancer. 2019 Jul;116:190-198. doi: 10.1016/j.ejca.2019.05.012. Epub 2019 Jun 13.

PMID:
31203194
41.

Barriers to Accrual and Enrollment in Brain Tumor Trials.

Lee EQ, Chukwueke UN, Hervey-Jumper SL, de Groot JF, Leone JP, Armstrong TS, Chang SM, Arons D, Oliver K, Verble K, Musella A, Willmarth N, Alexander BM, Bates A, Doherty L, Galanis E, Gaffey S, Halkin T, Friday BE, Fouladi M, Lin NU, Macdonald D, Mehta MP, Penas-Prado M, Vogelbaum MA, Sahebjam S, Sandak D, van den Bent M, Weller M, Reardon DA, Wen PY.

Neuro Oncol. 2019 Jun 7. pii: noz104. doi: 10.1093/neuonc/noz104. [Epub ahead of print]

PMID:
31175826
42.

DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical management.

Nassiri F, Mamatjan Y, Suppiah S, Badhiwala JH, Mansouri S, Karimi S, Saarela O, Poisson L, Gepfner-Tuma I, Schittenhelm J, Ng HK, Noushmehr H, Harter P, Baumgarten P, Weller M, Preusser M, Herold-Mende C, Tatagiba M, Tabatabai G, Sahm F, von Deimling A, Zadeh G, Aldape KD; International Consortium on Meningiomas .

Neuro Oncol. 2019 Jun 3. pii: noz061. doi: 10.1093/neuonc/noz061. [Epub ahead of print]

PMID:
31158293
43.

Defining EGFR amplification status for clinical trial inclusion.

French PJ, Eoli M, Sepulveda JM, de Heer I, Kros JM, Walenkamp A, Frenel JS, Franceschi E, Clement PM, Weller M, Ansell P, Looman J, Bain E, Morfouace M, Gorlia T, van den Bent M.

Neuro Oncol. 2019 Oct 9;21(10):1263-1272. doi: 10.1093/neuonc/noz096.

44.

Equal Footing of Thermal Expansion and Electron-Phonon Interaction in the Temperature Dependence of Lead Halide Perovskite Band Gaps.

Francisco-López A, Charles B, Weber OJ, Alonso MI, Garriga M, Campoy-Quiles M, Weller MT, Goñi AR.

J Phys Chem Lett. 2019 Jun 6;10(11):2971-2977. doi: 10.1021/acs.jpclett.9b00876. Epub 2019 May 22.

PMID:
31091105
45.

Imaging necrosis during treatment is associated with worse survival in EORTC 26101 study.

Nowosielski M, Gorlia T, Bromberg JEC, Sahm F, Harting I, Kickingereder P, Brandes AA, Taphoorn MJB, Taal W, Domont J, Idbaih A, Campone M, Clement PM, Weller M, Fabbro M, Le Rhun E, Platten M, Golfinopoulos V, van den Bent MJ, Bendszus M, Wick W.

Neurology. 2019 Jun 11;92(24):e2754-e2763. doi: 10.1212/WNL.0000000000007643. Epub 2019 May 10.

PMID:
31076534
46.

[Challenges and future perspectives in neuro-oncology].

Tabatabai G, Weller M.

Nervenarzt. 2019 Jun;90(6):594-600. doi: 10.1007/s00115-019-0716-4. Review. German.

PMID:
31073670
47.

Mutational patterns and regulatory networks in epigenetic subgroups of meningioma.

Paramasivam N, Hübschmann D, Toprak UH, Ishaque N, Neidert M, Schrimpf D, Stichel D, Reuss D, Sievers P, Reinhardt A, Wefers AK, Jones DTW, Gu Z, Werner J, Uhrig S, Wirsching HG, Schick M, Bewerunge-Hudler M, Beck K, Brehmer S, Urbschat S, Seiz-Rosenhagen M, Hänggi D, Herold-Mende C, Ketter R, Eils R, Ram Z, Pfister SM, Wick W, Weller M, Grossmann R, von Deimling A, Schlesner M, Sahm F.

Acta Neuropathol. 2019 Aug;138(2):295-308. doi: 10.1007/s00401-019-02008-w. Epub 2019 May 8.

PMID:
31069492
48.

Vulnerability of invasive glioblastoma cells to lysosomal membrane destabilization.

Le Joncour V, Filppu P, Hyvönen M, Holopainen M, Turunen SP, Sihto H, Burghardt I, Joensuu H, Tynninen O, Jääskeläinen J, Weller M, Lehti K, Käkelä R, Laakkonen P.

EMBO Mol Med. 2019 Jun;11(6). pii: e9034. doi: 10.15252/emmm.201809034.

49.

Efficient Screening of Combinatorial Peptide Libraries by Spatially Ordered Beads Immobilized on Conventional Glass Slides.

Schwaar T, Lettow M, Remmler D, Börner HG, Weller MG.

High Throughput. 2019 Apr 30;8(2). pii: E11. doi: 10.3390/ht8020011.

50.

Differential Impact of Education Level, Occupation and Marital Status on Performance of the Papanicolaou Test among Women from Various Regions in Brazil

Açucena Vieira Alves S, Schiaveto de Souza A, Weller M, Pires Batiston A.

Asian Pac J Cancer Prev. 2019 Apr 29;20(4):1037-1044.

Supplemental Content

Loading ...
Support Center